Strong domestic growth masks export collapse; margins at risk in H2
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Critical error: call stated PAT 159 Cr; actual delivered 258.9 Cr (62% understatement). Export guidance vague; recovery pinned to geopolitical normalization.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Domestic business firing on all cylinders (revenue +14%, margins expanding) with India Gate scaling and regional rice beating targets. But export collapse (-31% YoY) and commodity inflation (paddy prices +30% in October) constrain H2. Margin sustainability is the central risk; the low-cost inventory advantage that drove Q2's 50% PAT growth will erode rapidly as new-crop paddy hits margins.
₹1727.4 Cr
Revenue · +14.3% YoY₹258.9 Cr
Reported PAT · +50.4% YoYExpanding
Margins · vs guidance: MixedDid the claims hold up?
Record quarterly revenue INR1,727 Cr, +14% YoY
METDelivered 1727.4 Cr, +14.3% YoY; matches call exactly
Domestic revenue grew 33% YoY
OVERSTATEDTotal revenue +14.3%, domestic ~80% of mix = ~20-26% domestic growth; detailed breakdown not disclosed
Export revenue -31% YoY in Q2
METDelivered no export breakdown; call states Q2 exports ~297 Cr vs prior ~432 Cr = -31% YoY
PAT 159 Cr with 14.6% margin
MISSDelivered PAT 258.9 Cr with 14.6% NPM; call's stated 159 Cr is 62% below actual
EBITDA margin 21.1% vs 16.6% prior year
METDelivered OPM 19.2%; EBITDA-to-revenue relationship not specified; margin expansion corroborated
10% domestic volume growth target for FY27
METReaffirmed in call; Q2 showed 18% domestic volume growth QoQ; on track
Regional rice 25% growth guidance
METQ2 delivered 42% YoY regional rice growth; beat guidance by 68%
Masala ₹25 Cr annualized by FY27 year-end
METH1 masala sales INR4.5 Cr (was INR3.1 Cr prior year); on track to reach ₹25 Cr annualized
Earnings quality
What changed since the last call
EBITDA margin guidance raised
UpgradePrior FY27 guidance 17-18%; now 17-19%. Q2 delivered 21.1%, suggesting confidence in upper band; still below Q1 unsustainable 23.8%.
Domestic volume growth maintained; exports slashed
Neutral10% FY27 domestic volume growth reaffirmed (on track for delivery). Export recovery now heavily contingent on geopolitical resolution; bulk business to Middle East effectively paused due to payment channel stress and freight costs.
Paddy price inflation outpacing volume growth
DowngradeNew-crop paddy prices up 30% in October (INR 4,500/qtn vs INR 3,500 baseline). H2 margin compression likely; realized ₹80/kg domestic realization will face upward cost pressure.
The Q&A
Analysts pressed hard on export recovery prospects, inventory margins, and H2 earnings. Management held firm on 10% volume growth but conceded paddy price risk; acknowledged low-cost inventory advantage is temporary. Deflected on absolute volume numbers (said 'not disclosing'). Overall tone: confident but cautious.
Export recovery outlook — Yash Dantewadia, Dante Equity
PartialExport recovery is Middle East-dependent. If Iran-US settlement occurs, exports could double (10,000-40,000 tons potential). Bulk sales to Iraq, Kuwait, Saudi Arabia contingent on freight normalization. Europe secondary market; 400,000 tons brown rice potential at ~₹550/ton premium.
Low-cost inventory sustainability — Yash Dantewadia, Dante Equity
AnsweredQ3 will be mix of old and new crop. Old crop has higher margins; new crop paddy quite high, margins would be comparatively lower. EBITDA likely 16-20% in Q3. New inventory for 1.5 years; will sell at market prices; profit will come eventually from SKU-mix leverage.
Domestic volume growth Q2 vs prior guidance — Chirag Singhal, First Water Fund
AnsweredConsumer pack growth accelerated 7% Q1 to 18% Q2. Bulk pack recovery in October shows strong trajectory. Regional rice +42% YoY. H1 level 32% growth; H2 may moderate but we expect 10% full-year growth achievable given structural tailwinds (bulk pack recovery, regional rice strength).
India Gate brand expansion & masala scaling — Yash Dantewadia, Dante Equity
AnsweredPoha reached 44% of existing rice outlet base in launch towns by mid-September. 30% of retailers reordered early signal. Masala H1 sales ₹4.5 Cr (vs ₹3.1 Cr prior year). Building ready-cook blends for regional dishes. Ambition remains ₹25 Cr annualized FY27 year-end run rate via Grams of Hope CSR (70k children reached) to build brand trust.
Dividend policy & capital allocation — Bhavi Chauhan, Care PMS
PartialPolicy is 15% of profit, but will discuss beyond that. Cash rich balance sheet; will look above 15% as well. Likely to discuss dividend payout shortly; will give good dividend.
Regional expansion strategy beyond Middle East — Anuj Sharma, SteadFort Investment Managers
AnsweredSouth Africa performed well this year; expanding African continent presence. Europe: importing ~400k tons brown rice; KRBL seeking 425-500k ton share (10% max threshold). Pakistan is competitor at ₹50/ton lower pricing. UAE/Doha market leaders; freight/shipment logistics only near-term challenge. Will distribute rather than set up offices in Gulf to avoid credit burden. Strategy: high-margin distributor model, not low-margin owned offices.
Guidance
FY27 domestic volume growth 10% (reaffirmed)
HighH1 volume growth 32%, H2 expected to moderate but sustain 10%+ run rate. Bulk pack October strong recovery; regional rice momentum continues.
Export recovery contingent on Iran-US normalization; potential 10,000-40,000 MT upside in bulk
LowCurrently zero exports to Iran (sanctions); if settled, could do 50,000 tons/year. Europe +14% H1 showing diversification. Freight cost normalization required.
FY27 EBITDA margin 17-19% (raised from prior 17-18%)
MediumQ2 delivered 21.1% (above midpoint). H2 pressure from paddy inflation (prices +30% October); margin likely to compress into 16-20% Q3 range, recover toward 19% by year-end if commodity prices stabilize.
Risks the call surfaced
Export volume dependency
HighBulk basmati exports are 41% of H1 revenue; Q2 exports -31% YoY to 297 Cr. Middle East comprises 75% of bulk sales. Strait of Hormuz disruption, Iran sanctions tightness, Saudi freight cost inflation all constraining volumes.
Commodity price inflation / paddy cost pressure
HighNew-crop basmati paddy prices rose sharply in late October to INR 4,500/qtn (30% up from baseline INR 3,500/qtn). Low-cost paddy inventory (2,203 Cr at Sept 30) provides 1.5 quarters of margin cushion; once exhausted, realized pricing (currently INR 80/kg) will face margin squeeze.
Revenue concentration and market competition
MediumBasmati rice is the core product (70%+ of revenue). Domestic market is fragmented; competitors include Anil Sthayi, Tirupati, other regional players. India Gate brand is leading (36% gen trade, 39.6% modern trade market share) but pricing power limited by commodity dynamics.
Earnings quality and guidance credibility
HighCall stated Q2 consolidated PAT as INR 159 Cr with 14.6% margin. Delivered result shows PAT 258.9 Cr (50.4% YoY growth). This is a 99 Cr or 62% discrepancy. Math check: 1727.4 Cr revenue × 14.6% = 252 Cr, supporting delivered figure. Call's 159 Cr number is unexplained and material understatement.
Management
Score 7/10. Direct, detailed on strategy (disciplined procurement, India Gate brand building, regional scaling). Transparency on Middle East headwinds and commodity price risks. Withheld absolute volume numbers ('not disclosing right now'). Critical issue: PAT figure misstated by 62%, suggesting either transcript error or material misstatement. Track record solid: FY27 Q1-Q2 delivered 32% H1 domestic growth (beat 10% annualized), 21.1% EBITDA (beat 17-18% band), 42% regional rice (beat 25% target). But export -31% YoY is significant miss vs implicit growth expectation. Low-cost inventory advantage being capitalized correctly but temporary.
1 · Nov–Dec 2026
Iran-US normalization talks; bulk export recovery of 10,000+ tons if settled
2 · Q3 FY27
New crop paddy prices peak; EBITDA margin guidance test (17-19% band)
3 · FY27 year-end
Masala annualized revenue reach ₹25 Cr target; India Gate brand scaling payout
Margin sustainability is the central risk; the low-cost inventory advantage that drove Q2's 50% PAT growth will erode rapidly as new-crop paddy hits margins.
KRBL Q2 FY27: consolidated PAT up 50% YoY to ₹259 Cr, margin eases above guided band
PAT +50.44% YoY · revenue +14.32% · margins expanding
₹1,727.36 Cr
+14.32% YoY
₹258.93 Cr
+50.44% YoY
14.64%
+3.5pp YoY
₹11.31
KRBL's consolidated PAT came in at ₹258.9 Cr versus ₹172.1 Cr a year ago, up 50.4% YoY, on revenue of ₹1,727.4 Cr versus ₹1,511.1 Cr, up 14.3% YoY — profit growth clearly outpacing topline growth. Sequentially, revenue rose 15.5% over Q1 FY27's ₹1,495.9 Cr, but PAT was essentially flat (-0.7%) against Q1's ₹260.7 Cr print. EPS was ₹11.31, against ₹7.52 a year ago and ₹11.39 in Q1. Neither period carried exceptional items, so this is a clean reported comparison; standalone PAT of ₹259.0 Cr tracked the consolidated number almost exactly, with no divergence between the two bases worth flagging.
Q2 FY-2027 vs prior quarters
Net margin expanded to roughly 15.0% of revenue from 11.2% a year ago, and the operating (EBITDA) margin came in near 19.2% — above the 17-18% band management guided at its August 2026 concall, when it explicitly flagged Q1's 20.6% OPM as unsustainable and signalled normalization. That is exactly what played out: OPM eased roughly 130 bps QoQ from Q1's 20.6% while still clearing the top of its own guided range, making this a beat-and-normalize quarter rather than a miss. By segment, Agri (the core rice business) carried a PBT margin of about 19.3% on revenue of ₹1,715.3 Cr, up 14.9% YoY, while the much smaller Energy segment grew revenue 28.4% YoY to ₹74.0 Cr at a richer ~30.6% PBT margin.
The stock went into the print at ₹363, down 4.9% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
Maintaining 10% domestic volume growth for FY27; EBITDA margin 17-18% (down from unsustainable 23.8% this quarter); regional rice 25% growth; masala ₹25 Cr annualized by year-end.
— This quarter: beat
No management press release was extracted for this result, so there is nothing from the company's own words to cross-check against the numbers this quarter. The other disclosed developments — the AGM and FY26 annual report release, and the September trading-window closure — were procedural and don't bear on the P&L. The one live overhang is the ED's PMLA case tied to the JMD and the Agusta Westland allegations: the auditors have qualified their review report on it again this quarter, as they have in prior periods, with management's independent-firm review finding no conclusive evidence requiring adjustment. No analyst consensus estimate for this specific quarter could be confirmed via search, so the print is not graded against a street number here. Management's other FY27 targets from the last concall — 10% domestic volume growth, 25% regional rice growth, and a ₹25 Cr annualized masala run-rate by year-end — aren't verifiable from this filing, which breaks revenue out only by Agri and Energy segments.
W1
OPM trajectory toward the guided 17-18% band — this quarter printed ~19.2%, still above guidance; watch whether it continues normalizing in Q3
W2
Domestic volume growth (guided 10% for FY27), regional rice growth (guided 25%) and the masala ₹25 Cr annualized run-rate target by year-end — none disclosed in this filing's segment breakout; confirm in the Q3 concall
W3
Resolution of the ED/PMLA case tied to the JMD and Agusta Westland allegations — auditors have now qualified multiple consecutive review reports on this matter
Record Revenue, But Earnings Lean on Inventory Crutch
KRBL delivered record quarterly revenue of ₹1,727 Cr and PAT growth of +50.4%, but a critical discrepancy on the call—stated PAT of ₹159 Cr vs. delivered ₹259 Cr—raises earnings credibility concerns. More fundamentally, the profit surge rests on depleting low-cost paddy inventory, not organic business improvement.
₹259 Cr
+50.4% YoY
₹159 Cr
–62% discrepancy
14.6% NPM
EBITDA 21.1% (vs 16.6% prior year)
1.5 quarters
Then cost pressure begins
KRBL reported its highest-ever quarterly revenue at ₹1,727 Cr (+14.3% YoY) and a stunning 50.4% YoY jump in PAT to ₹259 Cr. On the surface, a blowout. But the headline obscures two material problems: a credibility gap on the call itself, and a profit surge built on temporary inventory advantage rather than business improvement.
The PAT discrepancy: credibility red flag
On the earnings call, CFO Ashish Jain stated Q2 consolidated PAT at ₹159 Cr with a 14.6% margin. The verified result filed with BSE shows ₹259 Cr—a ₹99 Cr gap or 62% understatement. The math checks: revenue of ₹1,727 Cr × 14.6% margin = ₹252 Cr, perfectly consistent with the delivered ₹259 Cr. The call's ₹159 Cr figure is unexplained and material. Management offered no clarification on the discrepancy.
PAT for the quarter was at INR159 crores or 14.6% in margin terms as against INR172 crores or 11.2% in the corresponding quarter.
Where the profit actually came from
Set the PAT misstatement aside; even the verified ₹259 Cr profit deserves scrutiny. KRBL's margin expansion—from 16.6% EBITDA last year to 21.1% this quarter—is real. But the driver is not organic business improvement. It is low-cost paddy inventory.
KRBL holds ₹2,203 Cr of paddy inventory at old-crop costs (purchased before prices spiked). This old inventory is being milled and sold at current market realization, pocketing the spread. But the runway is short: at current utilization, the company has 1.5 quarters of old-crop paddy left before it must source at new, inflated prices.
Domestic surge is real; export collapse is not
The one bright spot with sustainable legs is domestic growth. Q2 domestic revenue grew 33% YoY, driven by branded rice (+23% YoY, with consumer packs +31%) and regional rice (+42% YoY, nearly double the 25% guidance). India Gate brand continues to strengthen: market share stands at 36% in general trade and 39.6% in modern trade, up from ~33% prior year. Masala division is tracking toward the ₹25 Cr annualized target (H1 sales ₹4.5 Cr vs ₹3.1 Cr prior year).
But this domestic engine cannot fully mask the export wreck. Q2 exports fell 31% YoY to ~₹297 Cr, with bulk basmati volumes down to 2.5MT vs. 2.7MT prior year. The Middle East—which represents 75% of KRBL's export mix—remains in crisis. Payment channels are stressed (Iran sanctions), freight costs inflated, and the Strait of Hormuz transit risk has deterred shipments. Management's export recovery is contingent on Iran-US geopolitical normalization, with potential upside of 10,000–40,000 MT if settled. Until then, bulk business is effectively paused.
Record quarterly revenue ₹1,727 Cr, +14% YoY
Domestic growth 33% YoY
Regional rice +42% YoY (beats 25% guidance by 68%)
PAT 159 Cr stated on call
10% FY27 domestic volume growth (reaffirmed)
Export recovery contingent on Iran-US deal; no base-case scenario offered
What changed on this call
EBITDA margin guidance raised: Prior FY27 guidance was 17–18%; management now guides 17–19%. Q2 delivered 21.1%, suggesting confidence in the upper band. But the raise is more of a recalibration than an upgrade—Q2's 21.1% is likely unsustainable into H2 as new-crop paddy costs flow through. A 17–19% range is still below the Q2 run-rate and below the prior-year unsustainable 23.8%.
Domestic growth trajectory intact; exports reset downward: The 10% FY27 domestic volume growth guidance stands (on track for delivery given H1 32% growth). But export recovery is now explicitly tied to geopolitical outcomes, with management offering no volume or revenue guidance for a base-case scenario. This is a strategic de-risking; it also signals management does not expect near-term recovery.
Paddy cost risk acknowledged but not fully quantified: Ayush Gupta (Head-India Business) acknowledged paddy price inflation openly but deferred on precise margin impact. He guided Q3 EBITDA to 16–20%, a wide band that effectively says 'uncertain.' This is more honest than false precision, but it limits investor confidence in the margin trajectory.
How the street is positioned
KRBL stock closed at ₹405.1 as of November 9, 2026, trading well above its 20-day, 50-day, and 200-day simple moving averages (₹379, ₹394, ₹364 respectively). The stock is +47.5% off its 52-week low of ₹274.65 and –39.99% from its all-time high of ₹675, a substantial discount that reflects both sector headwinds and the market's caution on near-term earnings sustainability.
FII ownership has edged down: Foreign institutional investors held 7.28% in Q1 FY27 (down 0.48 percentage points from 7.76% in Q4 FY26), a modest but deliberate trim. This suggests foreign money is taking profits on the post-result rally or waiting for clarity on margin sustainability. Domestic institutional ownership is negligible at 0.70%, and promoter stake remains locked at 60.17%.
RSI at 60.2 sits in neutral territory—neither overbought nor oversold—consistent with a stock that has run from lows but not reached euphoric levels. Volume is normal. No bulk or block trades are flagged, suggesting no insider or promoter activity around the result.
Ranked risks for a holder
Paddy cost inflation eroding low-cost inventory advantage
High1.5 quarters of margin cushion remain. New-crop paddy prices +30% (INR 4,500/qtn). Once inventory depletes, Q3–Q4 will face upward cost pressure. 16–20% EBITDA in Q3 vs. 21.1% Q2 represents ~5 percentage point margin compression year-over-year unless pricing offsets.
PAT stated on call vs. delivered result—credibility gap
High₹99 Cr (62%) discrepancy between call figure and BSE filing unexplained. Raises questions about management disclosure discipline. If this reflects a misstatement rather than a one-time accounting item, investor trust is damaged.
Export business dependency on geopolitical normalization
HighBulk exports (41% of H1 revenue) are down 31% YoY and nearly paused due to Middle East payment stress, Hormuz transit risk, freight inflation. Recovery is explicitly contingent on Iran-US deal. No base-case guidance offered. If geopolitical resolution takes >12 months, KRBL forgoes ₹100+ Cr of revenue and must absorb costs.
Inventory accounting opacity
MediumPaddy inventory at ₹2,203 Cr is a material asset. Rapid depletion combined with sharp price move creates risk of margin cliff. Detailed visibility into blending strategy (old-crop vs. new-crop mix per unit) not disclosed; limits ability to model quarter by quarter.
Domestic growth moderation if consumer price elasticity bites
MediumDomestic growth of +33% YoY is strong but partly supported by pricing. If paddy costs force KRBL to raise consumer pack prices beyond +15–18% already taken, volume elasticity may kick in. Regional rice (the growth star at +42%) is price-sensitive.
The debate
The honest read: KRBL delivered a strong domestic quarter with real business momentum (regional rice +42% YoY, India Gate scaling). But the headline profit number is misleading. The +50.4% YoY PAT jump is not organic; it is a temporary spread on low-cost inventory that will vanish in H2. Export collapse (-31% YoY, >75% Middle East dependent) is a material drag and recovery is geopolitically uncertain. FY27 guidance is achievable on the volume side (10% domestic) but margin sustainability is the crux. The call's PAT discrepancy (159 vs. 259 Cr) is a red flag that erodes confidence in disclosure.
The verdict
Hold
Confidence 6/10
Strong
+33% YoY; India Gate scaling real
Weak
Inventory cushion exhausts in 1.5 qtrs
Q3 EBITDA margin
Test if guidance 17–19% holds or compresses below
1 · Q3 EBITDA margin trajectory
Management guided 16–20% for Q3 (wide band). The real test is whether realized margin tracks upper band (18–20%) or sinks toward lower band (16–17%). This will determine whether the high-margin inventory advantage is truly spent or merely compressing. If Q3 delivers <17%, expect material multiple compression.
2 · Iran-US geopolitical normalization and export timing
Management pegged export recovery to this outcome explicitly. Monitor news on US-Iran nuclear negotiations. If settlement occurs by Dec 2026 / Jan 2027, KRBL could see 10,000–40,000 MT recovery in bulk shipments by Q4 FY27, partially offsetting H2 margin pressure. If negotiations stall, export headwind persists into FY28.
3 · Paddy inventory mix shift and domestic pricing sustainability
As old-crop inventory depletes, monitor the pace of new-crop procurement and blended cost per unit. If KRBL is forced to raise domestic consumer pack prices by >18% to offset cost inflation, watch for volume elasticity in the Q3–Q4 print. Regional rice at +42% growth is most vulnerable to pricing.
4 · Management clarity on the PAT discrepancy
The 62% gap between call stated (₹159 Cr) and delivered (₹259 Cr) remains unexplained. At the Q3 earnings call, expect analysts to press hard on this. If management does not offer a clear explanation, credibility damage will widen. If they do explain (e.g., standalone vs. consolidated difference, a typo), it needs to be airtight.
KRBL delivered a headline-beating quarter on the back of strong domestic growth and profitable old-crop inventory drawdown. The market has correctly noted both: FII has trimmed slightly post-result, RSI sits neutral, and the stock holds the 52-week run-up from lows (+47.5%) without reaching excess. But the step-change in earnings is not here. This is a one-quarter inventory benefit overlaid on genuine domestic business progress. The single number to track from here is Q3 EBITDA margin. If it holds at or above 18%, management's guidance holds and the multiple may re-rate. If it sinks below 17%, the temporary nature of the Q2 surge becomes undeniable, and the stock will likely test lower. Domestic momentum is the only sustainable engine; on that alone, the company merits a hold, not a buy. The export recovery is a free option, not a base case.